Wenjin Cheng1,2, Chunyan Bu1, Fanling Hong1, Xiaozhu Zhong1,2, Chengyue Jin3, Xin Yang1,2, Xiuli Sun4,5, Jianliu Wang1,2. 1. Department of Obstetrics and Gynecology, Peking University People's Hospital, Peking University, Beijing, China. 2. Beijing Key Laboratory of Female Pelvic Floor Disorders, Beijing, China. 3. Department of Urology, Peking University People's Hospital, Peking University, Beijing, China. 4. Department of Obstetrics and Gynecology, Peking University People's Hospital, Peking University, Beijing, China. sunxiuli918@126.com. 5. Beijing Key Laboratory of Female Pelvic Floor Disorders, Beijing, China. sunxiuli918@126.com.
Abstract
INTRODUCTION AND HYPOTHESIS: We sought to assess the incidence, symptoms, and risk factors of perioperative hemorrhagic complications in patients undergoing pelvic floor reconstructive surgery. METHODS: This is a retrospective study on 694 consecutive patients who underwent pelvic floor reconstructive surgery with or without using mesh in our hospital over a 3-year period. RESULTS: We identified 694 pelvic floor reconstructive procedures from 2014 to 2016, including complete/incomplete colpocleisis (176, 25.4%), sacral colpopexy/hysteropexy with mesh (140, 20.1%), colporrhaphy (77, 11.1%) or vaginal mesh repair (99, 43.1%). Two patients who received only sacrospinous ligament suspension were excluded. There were 68 (9.8%) and 3 (0.1%) patients whose blood loss reached 200 and 500 ml respectively. Procedures involving mesh and vaginal hysterectomy (VH) caused more intraoperative blood loss. Postoperative hemoglobin drop was least in colpocleisis (p < 0.05). All 6 of the patients (0.9%) who developed postoperative pelvic hematoma underwent concomitant VH, and 5 of them received mesh. CONCLUSIONS: Hemorrhagic complications during or after pelvic floor reconstructive surgery are rare. Mesh use and concomitant VH are two major surgical risk factors for hemorrhagic complications in pelvic floor reconstructive surgery.
INTRODUCTION AND HYPOTHESIS: We sought to assess the incidence, symptoms, and risk factors of perioperative hemorrhagic complications in patients undergoing pelvic floor reconstructive surgery. METHODS: This is a retrospective study on 694 consecutive patients who underwent pelvic floor reconstructive surgery with or without using mesh in our hospital over a 3-year period. RESULTS: We identified 694 pelvic floor reconstructive procedures from 2014 to 2016, including complete/incomplete colpocleisis (176, 25.4%), sacral colpopexy/hysteropexy with mesh (140, 20.1%), colporrhaphy (77, 11.1%) or vaginal mesh repair (99, 43.1%). Two patients who received only sacrospinous ligament suspension were excluded. There were 68 (9.8%) and 3 (0.1%) patients whose blood loss reached 200 and 500 ml respectively. Procedures involving mesh and vaginal hysterectomy (VH) caused more intraoperative blood loss. Postoperative hemoglobin drop was least in colpocleisis (p < 0.05). All 6 of the patients (0.9%) who developed postoperative pelvic hematoma underwent concomitant VH, and 5 of them received mesh. CONCLUSIONS:Hemorrhagic complications during or after pelvic floor reconstructive surgery are rare. Mesh use and concomitant VH are two major surgical risk factors for hemorrhagic complications in pelvic floor reconstructive surgery.
Authors: Vivian W Sung; Sherry Weitzen; Eric R Sokol; Charles R Rardin; Deborah L Myers Journal: Am J Obstet Gynecol Date: 2006-05 Impact factor: 8.661
Authors: Mary P FitzGerald; Holly E Richter; Sohail Siddique; Peter Thompson; Halina Zyczynski Journal: Int Urogynecol J Pelvic Floor Dysfunct Date: 2005-06-28
Authors: Jai Hyung Park; Mohammad R Rasouli; S M Javad Mortazavi; Anthony T Tokarski; Mitchell G Maltenfort; Javad Parvizi Journal: J Bone Joint Surg Am Date: 2013-10-02 Impact factor: 5.284